D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RAPT holding history
RAPT Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RAPT overviewAll 13F holders of RAPTFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −83,923−100.0% | Sold out | Holders |
| Q1 2025 | 83,923 | $102.4K | <0.1% | −686,090−89.1% | Reduced | Holders |
| Q4 2024 | 770,013 | $1.22M | <0.1% | −278,173−26.5% | Reduced | Holders |
| Q3 2024 | 1,048,186 | $2.11M | <0.1% | +140,773+15.5% | Added | Holders |
| Q2 2024 | 907,413 | $2.77M | <0.1% | +637,272+235.9% | Added | Holders |
| Q1 2024 | 270,141 | $2.43M | <0.1% | +270,141 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −17,136−100.0% | Sold out | Holders |
| Q2 2023 | 17,136 | $320.4K | <0.1% | −78,926−82.2% | Reduced | Holders |
| Q1 2023 | 96,062 | $1.76M | <0.1% | −30,643−24.2% | Reduced | Holders |
| Q4 2022 | 126,705 | $2.51M | <0.1% | +27,225+27.4% | Added | Holders |
| Q3 2022 | 99,480 | $2.39M | <0.1% | +99,480 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −68,648−100.0% | Sold out | Holders |
| Q4 2021 | 68,648 | $2.52M | <0.1% | −59,120−46.3% | Reduced | Holders |
| Q3 2021 | 127,768 | $3.97M | <0.1% | +79,885+166.8% | Added | Holders |
| Q2 2021 | 47,883 | $1.52M | <0.1% | +47,883 | New | Holders |